Aemetis, Inc (AMTX) Stock Analysis and Metrics

Aemetis

NASDAQ: AMTX

$1.68 ▼ -0.17 (-8.92%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap112.56 Mn

P/E-1.21

P/S0.54

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)110.85 Mn

Revenue Growth (1y) (Qtr)27.36

Add ratio to table…

About

Aemetis, Inc. is an international renewable natural gas and renewable fuels company focused on the operation, acquisition, development, and commercialization of innovative technologies to produce low and negative carbon intensity renewable fuels that lower fuel costs and reduce emissions. The company builds a local circular bioeconomy using agricultural products and wastes to produce advanced renewable fuels that reduce greenhouse gas emissions and improve air quality. Its core activities include operating ethanol and biodiesel production facilities, developing dairy digester projects for renewable natural gas, and advancing sustainable aviation fuel and carbon capture initiatives.

Aemetis generates revenue through the sale of renewable fuels and associated environmental credits. Primary products include denatured fuel ethanol, wet distillers grains, distillers corn oil, condensed distillers solubles, undenatured alcohol, carbon dioxide, renewable natural gas, biodiesel, and refined glycerin. The company also earns revenue from federal Renewable Fuel Standard credits, California Low Carbon Fuel Standard credits, and federal Section 45Z production tax credits by selling these environmental attributes to third parties. Revenue is derived from sales to agricultural customers, transportation fuel markets, industrial users, and government oil marketing companies.

The company operates through the following segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel.

• California Ethanol: This segment owns and operates a 65 million gallon per year capacity ethanol production facility in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all sold as animal feed to local dairies and feedlots. The segment also sells CO₂ captured from ethanol fermentation to produce commercial grade CO₂ for the food, beverage, and other industries.

• California Dairy Renewable Natural Gas: This segment produces Renewable Natural Gas in central California using anaerobic digesters that process dairy waste. It includes a 36-mile biogas collection pipeline leading to a central RNG production facility and an interconnection to inject RNG into the utility natural gas pipeline for use as transportation fuel. The segment is building its own RNG fuel dispensing station, planned to begin operating in 2026, and is expanding with additional digesters under construction and agreements with over fifty dairies.

• India Biodiesel: This segment owns and operates a plant in Kakinada, India with a capacity to produce about 80 million gallons per year of high-quality distilled biodiesel from various vegetable oil and animal waste feedstocks. The Kakinada Plant also distills crude glycerin from biodiesel production into refined glycerin sold to the pharmaceutical, personal care, paint, adhesive, and other industries. The plant is one of the largest biodiesel production facilities in India and has developed proprietary technology to use lower-cost waste products as feedstock.

Aemetis holds a niche position in the renewable fuels industry by focusing on low and negative carbon intensity fuels, particularly in California where it produces ethanol amid competition from Midwestern and Brazilian imports. In the renewable natural gas market, it competes with other credit producers in D3 RINs and LCFS credit markets, leveraging its established dairy digester operations. In India, the Kakinada Plant competes with government-owned Oil Marketing Companies and private oil companies in the biodiesel blending market, relying on location, price, and quality to secure sales as a reliable supplier.

Aemetis serves a diverse customer base including local dairies and feedlots that purchase Wet Distillers Grains and Distillers Corn Oil from the Keyes Plant. The company sells ethanol to J. D. Heiskell, which resells to marketers, and has designated Murex LLC to purchase and resell ethanol to fuel blenders. A. L. Gilbert Co. distributes WDG from the Keyes Plant, and an industrial gas company purchases CO₂ from the facility. For renewable natural gas, the company sells RNG into the utility pipeline and environmental credits through industry brokers. In India, biodiesel and refined glycerin are sold to government Oil Marketing Companies including Hindustan Petroleum, Bharat Petroleum, and Indian Oil Corporation.

Investment Thesis

▲ Bull case

Aemetis, Inc. is positioned to capitalize on a significant structural shift in the renewable fuels market driven by the delayed but imminent publication of the updated 45z GREET model by the Department of Energy, which will unlock the fourth revenue stream for its sustainable aviation fuel (SAF) and renewable diesel (RD) projects. Management emphasized that while the federal 45z tax credit framework was passed and Treasury guidance issued in February 2026, the actual DOE calculator spreadsheet required to finalize credit calculations remains pending, creating a temporary financing bottleneck. Once published—expected before June 2026—the updated model will substantially increase the per-gallon value of 45z credits, directly enhancing the economics of the 80 million gallon/year SAF/RD plant at Keyes, California. This catalyst is particularly material because the plant already has full permitting, definitive off-take agreements with 10 airlines, and strong market validation from Phillips 66 running above nameplate capacity on renewable diesel, with neat SAF trading at $9.80/gallon in California. The company’s ability to monetize stacked credits—LCFS (from negative CI scores like -380), federal RINs, 45z, and the physical product—creates a margin profile far exceeding traditional fuel producers, with industry-reported operating margins of ~$1.60/gallon translating to over $128 million in annual EBITDA potential at full capacity, even before 45z uplift. The market is underestimating how quickly this credit stack can be monetized once the DOE model is live, especially given that Aemetis has already pre-financed equipment and begun construction, de-risking execution.
The India biodiesel segment represents a hidden catalyst for Aemetis, Inc. that extends far beyond the Q1 revenue rebound to $10.5 million, as management revealed a fundamental policy shift underway in India that will drive sustainable, multi-year growth and directly support the upcoming IPO of Universal Biofuels Private Limited. Despite current breakeven profitability, the company highlighted that the Indian government’s artificial suppression of diesel prices—maintaining January/February levels despite surging global crude costs—is poised to reverse imminently, triggering a cascading effect: Oil Marketing Companies (OMCs), currently losing money on every diesel sale, will be forced to raise prices and actively seek biodiesel blending to mitigate losses under the existing National Biofuels Policy mandating 5% blend in a 25 billion gallon market. With current blending at just 0.5%, the addressable opportunity is massive—1.25 billion gallons of potential demand—and Aemetis is uniquely positioned to capture it through its 80 million gallon plant operating at only 10% capacity, with ongoing negotiations to return to cost-plus contract structures that previously delivered $112 million in revenue and $14 million in positive cash flow. The IPO is being structured to correlate directly with policy adoption timing, meaning capital raised will not only expand domestic biodiesel but also fund conversion to sustainable aviation fuel (SAF) production in India, creating a globally diversified renewable fuels platform. This structural policy tailwind, combined with India’s >90% crude oil import dependence, creates a durable growth runway that the market is overlooking amid short-term Q1 volatility.
Aemetis, Inc.’s dairy RNG business is undergoing a scalable, capital-efficient expansion that is being underappreciated by investors focused solely on quarterly revenue, as the company’s strategy of monetizing Section 48 Investment Tax Credits (ITCs) in real-time creates a self-funding growth engine for digester deployment. Management disclosed that they have already sold approximately $95 million of ITCs from completed projects, typically in $5 million+ increments, with a goal of selling at least one project’s credits per quarter—providing immediate, non-dilutive cash to fund construction of additional digesters without relying on external debt or equity. This model is particularly powerful because each digester generates ITCs upon its in-service date, eliminating the need to wait for full portfolio completion, and the delay between completion and credit monetization is only about one month. With H2S cleanup and biogas compression skids for 15 additional digesters already contracted under a $27 million fabrication agreement—and four units already delivered—Aemetis is on track to double its operating dairy network into 2027, with each new digester qualifying for the high-value negative 380 carbon intensity pathway once CARB approval is secured (expected to shorten from 24–36 months to ~9 months under the new Tier 1 process). The resulting LCFS credit generation at these ultra-low CI scores will produce substantial ongoing revenue per MMBtu, and the company’s ability to recycle ITC proceeds into new projects means growth is not constrained by traditional capital availability, creating a compounding effect that is not reflected in current earnings estimates.

Aemetis, Inc. is positioned to capitalize on a significant structural shift in the renewable fuels market driven by the delayed but imminent publication of the updated 45z GREET model by the Department of Energy, which will unlock the fourth revenue stream for its sustainable aviation fuel (SAF) and renewable diesel (RD) projects. Management emphasized that while the federal 45z tax credit framework was passed and Treasury guidance issued in February 2026, the actual DOE calculator spreadsheet required to finalize credit calculations remains pending, creating a temporary financing bottleneck. Once published—expected before June 2026—the updated model will substantially increase the per-gallon value of 45z credits, directly enhancing the economics of the 80 million gallon/year SAF/RD plant at Keyes, California. This catalyst is particularly material because the plant already has full permitting, definitive off-take agreements with 10 airlines, and strong market validation from Phillips 66 running above nameplate capacity on renewable diesel, with neat SAF trading at $9.80/gallon in California. The company’s ability to monetize stacked credits—LCFS (from negative CI scores like -380), federal RINs, 45z, and the physical product—creates a margin profile far exceeding traditional fuel producers, with industry-reported operating margins of ~$1.60/gallon translating to over $128 million in annual EBITDA potential at full capacity, even before 45z uplift. The market is underestimating how quickly this credit stack can be monetized once the DOE model is live, especially given that Aemetis has already pre-financed equipment and begun construction, de-risking execution.
The India biodiesel segment represents a hidden catalyst for Aemetis, Inc. that extends far beyond the Q1 revenue rebound to $10.5 million, as management revealed a fundamental policy shift underway in India that will drive sustainable, multi-year growth and directly support the upcoming IPO of Universal Biofuels Private Limited. Despite current breakeven profitability, the company highlighted that the Indian government’s artificial suppression of diesel prices—maintaining January/February levels despite surging global crude costs—is poised to reverse imminently, triggering a cascading effect: Oil Marketing Companies (OMCs), currently losing money on every diesel sale, will be forced to raise prices and actively seek biodiesel blending to mitigate losses under the existing National Biofuels Policy mandating 5% blend in a 25 billion gallon market. With current blending at just 0.5%, the addressable opportunity is massive—1.25 billion gallons of potential demand—and Aemetis is uniquely positioned to capture it through its 80 million gallon plant operating at only 10% capacity, with ongoing negotiations to return to cost-plus contract structures that previously delivered $112 million in revenue and $14 million in positive cash flow. The IPO is being structured to correlate directly with policy adoption timing, meaning capital raised will not only expand domestic biodiesel but also fund conversion to sustainable aviation fuel (SAF) production in India, creating a globally diversified renewable fuels platform. This structural policy tailwind, combined with India’s >90% crude oil import dependence, creates a durable growth runway that the market is overlooking amid short-term Q1 volatility.
Aemetis, Inc.’s dairy RNG business is undergoing a scalable, capital-efficient expansion that is being underappreciated by investors focused solely on quarterly revenue, as the company’s strategy of monetizing Section 48 Investment Tax Credits (ITCs) in real-time creates a self-funding growth engine for digester deployment. Management disclosed that they have already sold approximately $95 million of ITCs from completed projects, typically in $5 million+ increments, with a goal of selling at least one project’s credits per quarter—providing immediate, non-dilutive cash to fund construction of additional digesters without relying on external debt or equity. This model is particularly powerful because each digester generates ITCs upon its in-service date, eliminating the need to wait for full portfolio completion, and the delay between completion and credit monetization is only about one month. With H2S cleanup and biogas compression skids for 15 additional digesters already contracted under a $27 million fabrication agreement—and four units already delivered—Aemetis is on track to double its operating dairy network into 2027, with each new digester qualifying for the high-value negative 380 carbon intensity pathway once CARB approval is secured (expected to shorten from 24–36 months to ~9 months under the new Tier 1 process). The resulting LCFS credit generation at these ultra-low CI scores will produce substantial ongoing revenue per MMBtu, and the company’s ability to recycle ITC proceeds into new projects means growth is not constrained by traditional capital availability, creating a compounding effect that is not reflected in current earnings estimates.

▼ Bear case

Aemetis, Inc. faces material execution risk in its flagship 80 million gallon/year SAF and renewable diesel project at Keyes, California, despite management’s optimistic financing commentary, as the company continues to rely on the unresolved uncertainty surrounding the Department of Energy’s updated 45z GREET model to secure financing—a dependency that could delay or derail the project if the model’s output disappoints or is further postponed. While Eric McAfee expressed confidence that the model will be published before June 2026 and emphasized that “the business works great without 45z,” the financing strategy remains contingent on lenders needing visibility into this fourth revenue stream, and any delay beyond the expected timeline—or a less favorable credit calculation than anticipated—would directly impact the project’s economics, especially given the $800 million revenue potential cited is contingent on both full capacity utilization and favorable credit stacking. The company has already invested heavily in equipment (with major components on-site) and begun construction, creating sunk cost pressure, yet there is no discussion of contingency plans if 45z credits fall short of expectations, nor has management addressed how a potential prolonged delay in DOE model publication would affect covenant compliance on existing bridge financing from Third Eye Capital. This overreliance on a single external catalyst, combined with the vague reference to “making progress on financing,” suggests the market may be underestimating the execution risk in what is portrayed as a near-certain, high-margin venture.
The India biodiesel segment’s apparent recovery in Q1—rebounding to $10.5 million in revenue—may be misleading and unsustainable, as Aemetis, Inc. is exposed to significant policy and operational risks in India that management downplayed by attributing current breakeven profitability solely to temporary government price suppression, without addressing deeper structural challenges in feedstock supply, logistics, and competing priorities within the National Biofuels Policy. While Eric McAfee highlighted the impending diesel price increase and renewed OMC interest in cost-plus contracts, he did not disclose any concrete progress on securing long-term, volume-based agreements beyond discussions, nor did he address the persistent issue of feedstock volatility—particularly given the 20% tariff on key inputs (like used cooking oil) that previously devastated margins and caused OMCs to refuse delivery. Furthermore, the company’s claim of being “the largest biodiesel producer in India” operates in a market where blending is currently at just 0.5% of a 25 billion gallon pool, indicating minimal infrastructure and entrenched reliance on fossil diesel, with no mention of how Aemetis plans to overcome distribution bottlenecks or secure reliable access to non-edible feedstocks at scale. The IPO of Universal Biofuels Private Limited is being positioned as a breakout opportunity, yet the use of proceeds remains vaguely tied to “expanding existing projects” and potential SAF conversion, with no clarity on how much capital will be allocated to working capital needs versus growth capex, raising concerns that the IPO may primarily serve to refinance existing India debt rather than fund scalable, profitable expansion—a nuance lost in the optimistic narrative around policy tailwinds.
Aemetis, Inc.’s dairy RNG growth strategy, while presented as a self-funding engine via Section 48 ITC monetization, carries significant execution and market risks that are not being adequately scrutinized, particularly the assumption that CARB approval timelines for new digester pathways will shorten dramatically from the historical 24–36 months to approximately nine months under the new Tier 1 process—a shift that lacks concrete evidence in the transcript and depends entirely on regulatory cooperation that may not materialize as expected. Andy Foster’s commentary on the approval process being “significantly shorter” now that CARB has moved to Tier 1 was presented as optimistic speculation without any basis in recent approvals or official guidance, and the company’s reliance on this acceleration to justify the negative 380 CI score (and thus elevated LCFS revenue) for digesters not yet built introduces substantial uncertainty. Furthermore, the strategy of selling ITCs in $5 million+ increments to fund new projects assumes a consistently deep and liquid market for these credits, yet there was no discussion of potential buyer concentration, pricing pressure, or how a slowdown in corporate or institutional demand for tax credits (e.g., due to changes in corporate tax appetite or alternative investment options) could disrupt this recycling mechanism. With $6.5 million in capital invested during Q1 alone on carbon intensity reduction and dairy digester construction, and no clear disclosure of the current burn rate or remaining capital needs for the $27 million skid contract and $40 million MVR project, the company risks overextending its balance sheet if ITC sales do not keep pace with construction outlays, especially given the already narrow cash position of $4.8 million at quarter-end.

Aemetis, Inc. faces material execution risk in its flagship 80 million gallon/year SAF and renewable diesel project at Keyes, California, despite management’s optimistic financing commentary, as the company continues to rely on the unresolved uncertainty surrounding the Department of Energy’s updated 45z GREET model to secure financing—a dependency that could delay or derail the project if the model’s output disappoints or is further postponed. While Eric McAfee expressed confidence that the model will be published before June 2026 and emphasized that “the business works great without 45z,” the financing strategy remains contingent on lenders needing visibility into this fourth revenue stream, and any delay beyond the expected timeline—or a less favorable credit calculation than anticipated—would directly impact the project’s economics, especially given the $800 million revenue potential cited is contingent on both full capacity utilization and favorable credit stacking. The company has already invested heavily in equipment (with major components on-site) and begun construction, creating sunk cost pressure, yet there is no discussion of contingency plans if 45z credits fall short of expectations, nor has management addressed how a potential prolonged delay in DOE model publication would affect covenant compliance on existing bridge financing from Third Eye Capital. This overreliance on a single external catalyst, combined with the vague reference to “making progress on financing,” suggests the market may be underestimating the execution risk in what is portrayed as a near-certain, high-margin venture.
The India biodiesel segment’s apparent recovery in Q1—rebounding to $10.5 million in revenue—may be misleading and unsustainable, as Aemetis, Inc. is exposed to significant policy and operational risks in India that management downplayed by attributing current breakeven profitability solely to temporary government price suppression, without addressing deeper structural challenges in feedstock supply, logistics, and competing priorities within the National Biofuels Policy. While Eric McAfee highlighted the impending diesel price increase and renewed OMC interest in cost-plus contracts, he did not disclose any concrete progress on securing long-term, volume-based agreements beyond discussions, nor did he address the persistent issue of feedstock volatility—particularly given the 20% tariff on key inputs (like used cooking oil) that previously devastated margins and caused OMCs to refuse delivery. Furthermore, the company’s claim of being “the largest biodiesel producer in India” operates in a market where blending is currently at just 0.5% of a 25 billion gallon pool, indicating minimal infrastructure and entrenched reliance on fossil diesel, with no mention of how Aemetis plans to overcome distribution bottlenecks or secure reliable access to non-edible feedstocks at scale. The IPO of Universal Biofuels Private Limited is being positioned as a breakout opportunity, yet the use of proceeds remains vaguely tied to “expanding existing projects” and potential SAF conversion, with no clarity on how much capital will be allocated to working capital needs versus growth capex, raising concerns that the IPO may primarily serve to refinance existing India debt rather than fund scalable, profitable expansion—a nuance lost in the optimistic narrative around policy tailwinds.
Aemetis, Inc.’s dairy RNG growth strategy, while presented as a self-funding engine via Section 48 ITC monetization, carries significant execution and market risks that are not being adequately scrutinized, particularly the assumption that CARB approval timelines for new digester pathways will shorten dramatically from the historical 24–36 months to approximately nine months under the new Tier 1 process—a shift that lacks concrete evidence in the transcript and depends entirely on regulatory cooperation that may not materialize as expected. Andy Foster’s commentary on the approval process being “significantly shorter” now that CARB has moved to Tier 1 was presented as optimistic speculation without any basis in recent approvals or official guidance, and the company’s reliance on this acceleration to justify the negative 380 CI score (and thus elevated LCFS revenue) for digesters not yet built introduces substantial uncertainty. Furthermore, the strategy of selling ITCs in $5 million+ increments to fund new projects assumes a consistently deep and liquid market for these credits, yet there was no discussion of potential buyer concentration, pricing pressure, or how a slowdown in corporate or institutional demand for tax credits (e.g., due to changes in corporate tax appetite or alternative investment options) could disrupt this recycling mechanism. With $6.5 million in capital invested during Q1 alone on carbon intensity reduction and dairy digester construction, and no clear disclosure of the current burn rate or remaining capital needs for the $27 million skid contract and $40 million MVR project, the company risks overextending its balance sheet if ITC sales do not keep pace with construction outlays, especially given the already narrow cash position of $4.8 million at quarter-end.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Specialty Chemicals

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	LIN	Linde Plc	237.95 Bn	33.52	6.87	24.68 Bn
2	SHW	Sherwin Williams Co	78.17 Bn	30.07	3.27	11.70 Bn
3	ECL	Ecolab Inc.	76.02 Bn	30.01	4.73	8.24 Bn
4	APD	Air Products & Chemicals, Inc.	66.38 Bn	47.14	5.33	17.40 Bn
5	PPG	Ppg Industries Inc	26.02 Bn	3,717.41	1.61	7.83 Bn
6	LYB	LyondellBasell Industries N.V.	22.51 Bn	-28.53	0.76	11.45 Bn
7	SQM	Chemical & Mining Co Of Chile Inc	19.70 Bn	21.77	3.72	4.79 Bn
8	IFF	International Flavors & Fragrances Inc	19.51 Bn	-102.16	1.81	5.82 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password